Status:
TERMINATED
Assessment of Biologic Parameters in Preparation for Future Malaria Vaccine Trials in Don gu Bougou, Mali
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Malaria
Eligibility:
All Genders
Up to 45 years
Brief Summary
There are about 300-500 million cases of malaria worldwide each year, with 2-3 million deaths. Plasmodium falciparum, one of four types of malaria, is responsible for most of these deaths. Because of ...
Detailed Description
Doneguebougou, Mali, is an area of seasonal malaria transmission that is being investigated as a suitable site for testing investigational malaria vaccines. The overall goal of this study is to charac...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Males or females aged 6 months to 45 years.
- Resident of Doneguebougou at the start of the study, and intent to remain a resident for the duration of the study.
- Willingness to participate in the study as evidenced by the completed informed consent document.
- EXCLUSION CRITERIA:
- Clinical evidence of acute life-threatening illness requiring immediate medical care.
Exclusion
Key Trial Info
Start Date :
July 1 2002
Trial Type :
OBSERVATIONAL
End Date :
July 1 2005
Estimated Enrollment :
515 Patients enrolled
Trial Details
Trial ID
NCT00341783
Start Date
July 1 2002
End Date
July 1 2005
Last Update
January 7 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute of Allergy and Infectious Diseases (NIAID)
Bethesda, Maryland, United States, 20892